Britain has signed deals to secure 90 million doses of two possible Covid-19 vaccines from the Pfizer and BioNTech alliance, and French group Valneva.
Britain had secured 30 million doses of the experimental BioNTech/Pfizer vaccine, and a deal in principle for 60 million doses of the Valneva vaccine, with an option of 40 million more doses if it was proven to be safe, effective and suitable, the business ministry said.
Financial terms of the deals were not confirmed. "This new partnership with some of the world's foremost pharmaceutical and vaccine companies will ensure the UK has the best chance possible of securing a vaccine that protects those most at risk," business minister Alok Sharma said.